Leading spatial biology revolution with its GeoMx Digital Spatial Profiler. Razor blade business model ensures consistent revenue growth on increased utilization of innovative panels. Leading platform with over 2,800 peer-reviewed publications.

Software subscription model, high retention rate, its own drug discovery business consisting of collaborative programs and its own internal pipeline shows the disruptive potential of this platform.

Software subscription model, high retention rate, solid revenue growth supported from increased utilization. Platform has massive and growing data set that includes 332M unique patients , 61B medical events and large footprint across the entire healthcare ecosystem.

Foundation medicine (FMI) acquired by Roche in 2018 for $2.4 billion